Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bellevue Life Sciences Acquisition Corp. BLAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
15/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bellevue Life Sciences Acquisition Corp. (BLAC) is a Shell Companies company in the Financial Services sector, currently trading at $3.01. It has a SharesGrow Score of 14/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $3M, +0%/yr average growth. Net income is $29M (loss), growing at -184.8%/yr. Net profit margin is -994.2% (negative). Gross margin is 20.4% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Debt-to-assets is 0%. Total assets: $2M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 0/100 (Fail), Moat 25/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BLAC SharesGrow Score Overview

19/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 25/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BLAC

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
BLAC: +0%/yr revenue is, -184.8%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
BLAC: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
25/100
BLAC: Gross margin is 20.4% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 25/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BLAC: Net profit margin is -994.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range3.01-13.4
Volume430.77K
Avg Volume (30D)15.26K
Market Cap$6.98M
Beta (1Y)0.53
Share Statistics
IPO Date2023-03-21
CEOKuk Hyoun Hwang
Financial Highlights & Ratios
Revenue (TTM)$2.91M
Gross Profit$592.91K
EBITDA$-18.34M
Net Income$-28.89M
Operating Income$-18.34M
Total Cash$1.7M
Net Debt$-1.7M
Total Assets$1.7M
Price / Sales (P/S)2.4
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS68840D1028

Price Chart

Track all markets on TradingView
BLAC
Bellevue Life Sciences Acquisition Corp. ↗  ·  NASDAQ Capital Marke
Financial Services • Shell Companies
3.01 52WK RANGE 13.40

People Also View

VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$164.90
+1.12%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$309.37
+1.11%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$164.92
+1.12%
 PMFLX
PMFLX
PIMCO Flexible Municipal Income Fund
$10.12
+0.00%
 VOO
VOO
Vanguard S&P 500 ETF
$638.39
+1.22%
 VFIAX
VFIAX
Vanguard 500 Index Fund Admiral Shares
$635.71
+1.02%
 VFFSX
VFFSX
Vanguard 500 Index Fund
$337.06
+1.02%
 VFINX
VFINX
Vanguard 500 Index Fund
$635.82
+1.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message